Lifevantage Corp (LFVN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Darren Jensen
Employees:
227
9785 S. MONROE STREET, SUITE 300, SANDY, UT 84070
801-432-9000

LifeVantage Corp. is a science-based company. It engages in the identification, research, development, manufacture, and distribution of an advanced nutraceutical dietary supplement, including products Protandim; the Nrf2 Synergizer; Axio, anti-aging skin care product; LifeVantage TrueScience; and Canine Health. The firm operates through the Americas; and Asia or Pacific geographical segments. It currently focuses on oxidative stress solutions, particularly the activation of nuclear factor which relates to cardiovascular, central nervous system, inflammatory, and metabolic diseases as well as other health related disorders. The company was founded in June 1988 and is headquartered in Sandy, UT.

Data derived from most recent annual or quarterly report
Market Cap 52.431 Million Shares Outstanding12.851 Million Avg 30-day Volume 47.623 Thousand
P/E Ratio8.3743 Dividend Yield0.0 EPS0.17
Price to Revenue0.3965 Debt to Equity0.42 EBITDA17.3 Million
Price to Book Value2.4141 Operating Margin6.1027 Enterprise Value76.19 Million
Current Ratio1.93 EPS Growth-0.088 Quick Ratio1.019
1 Yr BETA 0.6889 52-week High/Low 8.6 / 3.77 Profit Margin4.7346
Operating Cash Flow Growth-8.3903 Altman Z-Score3.3251 Free Cash Flow to Firm -2.841 Million
Earnings Report2022-08-18
View SEC Filings from LFVN instead.

View recent insider trading info

Funds Holding LFVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LFVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

658 total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NEUFELD ALISSA GENERAL COUNSEL

  • Officer
37,536 2022-04-26 3

FIFE STEVEN R PRESIDENT AND CEO

  • Officer
  • Director
210,562 2022-04-01 7

LATHAM CYNTHIA

  • Director
11,364 2022-02-17 2

BEINDORFF MICHAEL A

  • Director
84,312 2022-02-07 3

ROSE JUSTIN CHIEF SALES OFFICER

  • Officer
174,575 2022-01-01 6

BROCKOVICH ERIN

  • Director
26,328 2021-11-12 1

GREER RAYMOND B

  • Director
62,854 2021-11-12 1

MAURO GARRY PAUL

  • Director
184,939 2021-11-12 1

LEWIS DARWIN

  • Director
64,854 2021-11-12 1

AURE CARL CHIEF FINANCIAL OFFICER

  • Officer
80,000 2021-11-12 2

COOLEY MATTHEW CHIEF OPERATING OFFICER

  • Officer
68,810 2021-08-12 2

WACH CHARLES J. CHIEF OPERATING OFFICER

  • Officer
37,605 2021-04-01 0

MCMURRAY KEVIN GENERAL COUNSEL

  • Officer
No longer subject to file 2021-04-01 0

MCMURRAY KEVIN GENERAL COUNSEL

BEINDORFF MICHAEL A

  • Officer
  • Director
49,725 2021-01-01 3

HEGDE VINAYAK

  • Director
50,373 2020-11-12 0

JENSEN DARREN JAY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
459,590 2020-08-28 0

GOODWIN RYAN CHIEF MARKETING OFFICER

  • Officer
149,343 2020-08-28 0

TOOLE DAVID J

  • Director
32,619 2018-02-02 0

METZGER GEORGE

  • Director
48,594 2018-02-02 0

WASHINGTON BEATRYX SENIOR VP AND GENERAL COUNSEL

  • Officer
0 2017-03-28 0

OKUMOTO RICHARD Y

  • Director
32,708 2017-02-16 0

MANOVICH DAVE

  • FORMER DIRECTOR
No longer subject to file 2017-02-16 0

JAGGI MARK R. CHIEF FINANCIAL OFFICER

  • Officer
15,665 2016-08-24 0

URBAN ROBERT M. CHIEF OPERATING OFFICER

  • Officer
33,881 2016-06-24 0

COLBERT DAVID CHIEF FINANCIAL OFFICER

  • Officer
193,850 2015-06-24 0

CUTLER ROB GENERAL COUNSEL

  • Officer
302,484 2015-04-06 0

TALBOTT SHAWN M. CHIEF SCIENCE OFFICER

  • Officer
56,668 2015-02-17 0

OBORN MICHELLE VP HUMAN RESOURCES

  • Officer
86,855 2015-01-25 0

ROBINSON DOUGLAS C. PRESIDENT & CEO

  • Officer
  • Director
0 2015-01-02 0

PHELPS DAVID N. CHIEF SALES OFFICER

  • Officer
0 2015-01-02 0

SPEDDEN ELWOOD

  • Director
25,000 2012-11-14 0

WALLEY DARLENE R. CHIEF SCIENCE OFFICER

  • Officer
130,000 2012-11-14 0

THOMPSON RYAN SENIOR VP OF SALES

  • Officer
6,343 2012-09-14 0

LU C. MIKE

  • Director
3,104,500 2012-06-26 0

TIPPS GENE SENIOR VP OF OPERATIONS

  • Officer
0 2012-03-22 0

MCQUEEN CARRIE E CHIEF FINANCIAL OFFICER

  • Officer
0 2012-02-07 0

BROWN DAVID WHITNEY PRESIDENT, LIFEVANTAGE NETWORK

  • Officer
  • Director
0 2012-02-03 0

ZENGER KIRBY L CHIEF OPERATING OFFICER

  • Officer
0 2012-02-03 0

CRAPO JAMES D

  • Director
575,000 2011-12-13 0

MCCORD JOE M

  • Director
1,981,425 2011-05-25 0

JONES RICHARD DOUTRE

  • Director
0 2011-01-20 0

MANOVICH KAY STOUT

  • Director
0 2011-01-20 0

THOMPSON JACK R.

  • Director
0 2009-11-30 0

AMMAN BRADFORD K. CFO, TREASURER, SECRETARY

  • Officer
905,756 2009-03-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

NEUFELD ALISSA - Officer GENERAL COUNSEL

2022-04-28 16:07:28 -0400 2022-04-26 F 3,460 $4.04 d 37,536 direct 8.7179 5.641 15.8974 4 0.0 1

FIFE STEVEN R - Director - Officer PRESIDENT AND CEO

2022-04-05 17:57:44 -0400 2022-04-01 M 658 a 211,998 direct 1.5054 -1.2903 -10.9619 2.7957 3 -16.1395 17

FIFE STEVEN R - Director - Officer PRESIDENT AND CEO

2022-04-05 17:57:44 -0400 2022-04-01 F 2,095 $4.81 d 209,903 direct 1.5054 -1.2903 -10.9619 2.7957 3 -16.1395 17

FIFE STEVEN R - Director - Officer PRESIDENT AND CEO

2022-04-05 17:57:44 -0400 2022-04-01 M 658 d 659 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LIFEVANTAGE CORP LFVN 2022-05-20 22:15:03 UTC 0.194 0.626 500000
LIFEVANTAGE CORP LFVN 2022-05-20 21:45:03 UTC 0.194 0.626 500000
LIFEVANTAGE CORP LFVN 2022-05-20 21:15:03 UTC 0.194 0.626 500000
LIFEVANTAGE CORP LFVN 2022-05-20 20:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 20:15:05 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 19:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 19:15:04 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 18:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 18:15:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 17:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 17:15:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 16:45:04 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 16:15:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 15:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 15:15:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 14:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 14:15:04 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 13:45:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 13:15:03 UTC 0.1845 0.6355 500000
LIFEVANTAGE CORP LFVN 2022-05-20 12:45:03 UTC 0.1845 0.6355 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments